NCR3 and neoplasm: NKARs, such as NKG2D, DNAM-1 and NCRs NKp30, NKp44 and NKp46, interact with ligands frequently upregulated on tumor cells, thereby promoting NK cell activation, cytokine production and the elimination of tumor cells (1).